Thursday, one of those generic manufacturers, Perrigo, issued a statement to clarify its status in the first case heard in the U.S.—George Bayer vs. Boehringer Ingelheim, et al.—in which the plaintiff moved this week for a voluntary dismissal after being hospitalized.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,